Abstract 1664: Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma

Joshua M. Walker; Diego M. Barragan; Melissa J. Kasiewicz; Charles R. Thomas; William L. Redmond

doi:10.1158/1538-7445.AM2016-1664

Abstract 1664: Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma

Joshua M. Walker
, Diego M. Barragan
, Melissa J. Kasiewicz
, Charles R. Thomas
, William L. Redmond

Research output: Other contribution

Original language	American English
DOIs	https://doi.org/10.1158/1538-7445.AM2016-1664
State	Published - Jul 15 2016

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Access to Document

10.1158/1538-7445.AM2016-1664License: Unspecified

Cite this

@misc{cc6f68e4cd9741b0b85d53e4d0468c41,

title = "Abstract 1664: Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma",

author = "Walker, \{Joshua M.\} and Barragan, \{Diego M.\} and Kasiewicz, \{Melissa J.\} and Thomas, \{Charles R.\} and Redmond, \{William L.\}",

note = "Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA Immunotherapy has now emerged as a promising treatment for metastatic cancer. However, immunotherapy for advanced stage breast carcinoma remains an unmet need.",

year = "2016",

month = jul,

day = "15",

doi = "10.1158/1538-7445.AM2016-1664",

language = "American English",

type = "Other",

}

TY - GEN

T1 - Abstract 1664: Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma

AU - Walker, Joshua M.

AU - Barragan, Diego M.

AU - Kasiewicz, Melissa J.

AU - Thomas, Charles R.

AU - Redmond, William L.

N1 - Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA Immunotherapy has now emerged as a promising treatment for metastatic cancer. However, immunotherapy for advanced stage breast carcinoma remains an unmet need.

PY - 2016/7/15

Y1 - 2016/7/15

UR - http://cancerres.aacrjournals.org/content/76/14_Supplement/1664

U2 - 10.1158/1538-7445.AM2016-1664

DO - 10.1158/1538-7445.AM2016-1664

M3 - Other contribution

ER -

Abstract 1664: Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma

Disciplines

Access to Document

Other files and links

Cite this